Progress and challenges in sporadic late-onset cerebellar ataxias

Klockgether, T. Sporadic ataxia with adult onset: classification and diagnostic criteria. Lancet Neurol. 9, 94–104 (2010).

Article  PubMed  CAS  Google Scholar 

Teive, H. A. G. & Ashizawa, T. Primary and secondary ataxias. Curr. Opin. Neurol. 28, 413–422 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Coarelli, G. et al. The inherited cerebellar ataxias: an update. J. Neurol. 270, 208–222 (2023).

Article  PubMed  Google Scholar 

Divya, K. P. & Kishore, A. Treatable cerebellar ataxias. Clin. Park. Relat. Disord. 3, 100053 (2020).

Google Scholar 

Muñiz-Castrillo, S. et al. Novelties in autoimmune and paraneoplastic cerebellar ataxias: twenty years of progresses. Cerebellum 21, 573–591 (2022).

Article  PubMed  Google Scholar 

Mitoma, H., Hadjivassiliou, M. & Honnorat, J. Guidelines for treatment of immune-mediated cerebellar ataxias. Cerebellum Ataxias 2, 14 (2015).

Article  PubMed  PubMed Central  Google Scholar 

Joubert, B. & Honnorat, J. Nonparaneoplastic autoimmune cerebellar ataxias. Curr. Opin. Neurol. 32, 484–492 (2019).

Article  PubMed  Google Scholar 

Hadjivassiliou, M. et al. Diagnostic criteria for primary autoimmune cerebellar ataxia — guidelines from an international task force on immune-mediated cerebellar ataxias. Cerebellum 19, 605–610 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Narayan, R. N., McKeon, A. & Fife, T. D. Autoimmune vestibulocerebellar syndromes. Semin. Neurol. 40, 97–115 (2020).

Article  PubMed  Google Scholar 

Simard, C. et al. Clinical spectrum and diagnostic pitfalls of neurologic syndromes with Ri antibodies. Neurol. Neuroimmunol. Neuroinflamm. 7, e699 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Irani, S. R. et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia. Brain 133, 2734–2748 (2010).

Article  PubMed  PubMed Central  Google Scholar 

Lancaster, E. et al. Investigations of CASPR2, an autoantigen of encephalitis and neuromyotonia. Ann. Neurol. 69, 303–311 (2011).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Joubert, B. et al. Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis. Neurol. Neuroimmunol. Neuroinflamm. 4, e371 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Becker, E. B. et al. Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia. J. Neurol. Neurosurg. Psychiatry 83, 437–440 (2012).

Article  PubMed  Google Scholar 

Benoit, J. et al. Early-stage contactin-associated protein-like 2 limbic encephalitis: clues for diagnosis. Neurol. Neuroimmunol. Neuroinflamm. 10, e200041 (2023).

Article  PubMed  Google Scholar 

Mandel-Brehm, C. et al. Kelch-like protein 11 antibodies in seminoma-associated paraneoplastic encephalitis. N. Engl. J. Med. 381, 47–54 (2019).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hadjivassiliou, M., Sanders, D. S., Woodroofe, N., Williamson, C. & Grünewald, R. A. Gluten ataxia. Cerebellum 7, 494–498 (2008).

Article  PubMed  CAS  Google Scholar 

Gaig, C. et al. Clinical manifestations of the anti-IgLON5 disease. Neurology 88, 1736–1743 (2017).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Honorat, J. A. et al. IgLON5 antibody: neurological accompaniments and outcomes in 20 patients. Neurol. Neuroimmunol. Neuroinflamm. 4, e385 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Gaig, C. et al. Frequency and characterization of movement disorders in anti-IgLON5 disease. Neurology 97, e1367–e1381 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mitoma, H., Manto, M. & Hadjivassiliou, M. Immune-mediated cerebellar ataxias: clinical diagnosis and treatment based on immunological and physiological mechanisms. J. Mov. Disord. 14, 10–28 (2021).

Article  PubMed  PubMed Central  Google Scholar 

Chan, J. L., Murphy, K. A. & Sarna, J. R. Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J. Neurol. 268, 3517–3548 (2021).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162–173 (2018).

Article  PubMed  Google Scholar 

Montalban, X. et al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. N. Engl. J. Med. 376, 209–220 (2017).

Article  PubMed  CAS  Google Scholar 

Pittock, S. J. et al. Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 133, 2626–2634 (2010).

Article  PubMed  Google Scholar 

Tobin, W. O. et al. Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain 140, 2415–2425 (2017).

Article  PubMed  Google Scholar 

Mitoma, H. & Manto, M. Recent advances in diagnosis of immune-mediated cerebellar ataxias: novel concepts and fundamental questions on autoimmune mechanisms. J. Neurol. 271, 7046–7053 (2024).

Article  PubMed  Google Scholar 

Krismer, F., Fanciulli, A., Meissner, W. G., Coon, E. A. & Wenning, G. K. Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment. Lancet Neurol. 23, 1252–1266 (2024).

Article  PubMed  Google Scholar 

Bogdan, T. et al. Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study. J. Neurol. 269, 6354–6365 (2022).

Article  PubMed  CAS  Google Scholar 

Oender, D. et al. Evolution of clinical outcome measures and biomarkers in sporadic adult-onset degenerative ataxia. Mov. Disord. 38, 654–664 (2023).

Article  PubMed  CAS  Google Scholar 

Wenning, G. K. et al. The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov. Disord. 37, 1131–1148 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Virameteekul, S., Revesz, T., Jaunmuktane, Z., Warner, T. T. & De Pablo-Fernández, E. Pathological validation of the MDS criteria for the diagnosis of multiple system atrophy. Mov. Disord. 38, 444–452 (2023).

Article  PubMed  Google Scholar 

Sekiya, H. et al. Validation study of the MDS criteria for the diagnosis of multiple system atrophy in the Mayo Clinic Brain Bank. Neurology 101, e2460–e2471 (2023).

Article  PubMed  PubMed Central  CAS  Google Scholar 

Teive, H. A. G., Arruda, W. O., Moro, A., Moscovich, M. & Munhoz, R. P. Differential diagnosis of sporadic adult-onset ataxia: the role of REM sleep behavior disorder. Parkinsonism Relat. Disord. 21, 640–643 (2015).

Comments (0)

No login
gif